Dear Fellow Stockholders:
As we celebrated our 25th year in 2023, Akamai made tremendous progress toward realizing our goal to become the world’s most distributed cloud platform with leading solutions for content delivery, security, and cloud computing. With our strategy and expanded portfolio, we have transformed Akamai from a content delivery pioneer into the cloud company that powers and protects life online.
Total revenue in 2023 was $3.8 billion, up more than 5% year-over-year and up nearly 6% over 2022 adjusted for foreign exchange. For the first time ever, security represented the largest share of Akamai’s annual revenue, $1.8 billion, after growing 14% year-over-year and up 15% year-over-year adjusted for foreign exchange. This marked a significant milestone for our business since our expansion into security a decade ago. In another sign of our ability to expand Akamai’s business, our compute segment generated more than $500 million in revenue for the full year 2023, growing 24% year-over-year and up 25% year-over-year adjusted for foreign exchange. Combined, security and compute represented 60% of Akamai’s total revenue in 2023.
In addition to driving revenue expansion in rapidly growing market segments, we continued to optimize the business to enhance profitability. Akamai’s increased profitability resulted in enviable cash generation in 2023, as operating cash flow reached $1.35 billion.
We also continued to increase shareholder value by spending $654 million to buy back 7.8 million shares in 2023. Akamai has reduced the number of shares outstanding by approximately 15% since January 1, 2013. Akamai’s share price increased 40% in 2023, outperforming the S&P 500 (up 24%) while coming in slightly behind the NASDAQ composite (up 43%).
We are very excited about the growth opportunity we see in the large and rapidly growing cloud computing market, which Akamai entered in 2022 with our acquisition of Linode, our most significant acquisition in more than 20 years. Our plan is for cloud computing to become Akamai’s next billion-dollar business and the third pillar of our business along with content delivery and security.
We made great progress on our plan in 2023 with our launch of Akamai Connected Cloud and the rapid rollout of new core computing regions around the world, now 25 in total. This year, as part of our push to build the world’s most distributed cloud computing platform, Akamai plans to take cloud computing to the edge, by embedding cloud computing capabilities into our massive edge network that already powers our content delivery and security solutions.
From the day we entered this market, our cloud strategy has differed from the giant cloud providers’ centralized data center approach and the approaches of smaller CDN vendors who lack our network scale, performance, and global reach. By combining the computing power of our cloud platform with the proximity and efficiency of the edge, we are focused on positioning Akamai to put workloads closer to users, devices and sources of data than any other cloud provider. We are working to offer customers a new kind of cloud, one designed to meet the needs of modern applications that require higher performance, lower-latency, and true global scalability that current cloud architectures do not provide.
Last year, Akamai became a customer of our own cloud computing platform. By migrating workloads off of our previous cloud providers and onto Akamai Connected Cloud, we significantly reduced our spending with third-party cloud providers in 2023 and we plan to save even more in 2024. As a customer of our own cloud services, we gain unique insight into our value proposition for customers, helping us win customers through the power of our example and lessons learned from our experience as a customer.
In security, ransomware attacks continued to generate headlines in 2023, fueling customer interest in our market leading segmentation solution, which generated nearly $100 million in revenue last year. Application Security was another leading driver of Akamai’s security growth in 2023, as more customers identified API security risks as a top priority to manage. We expect these trends to continue to drive customer interest in Akamai’s security portfolio this year.
Our content delivery portfolio generated more than $1.5 billion in revenue in 2023. As the CDN leader, Akamai supports many of the world’s leading brands in delivering reliable, secure, and near-flawless online experiences.
Akamai’s business also benefits from strong synergy across our content delivery, security, and cloud computing offerings. Having all three product portfolios on one integrated platform enhances our top line when long-time delivery customers add our security and cloud computing products. And this synergy improves our bottom line as we capture the cost benefits of using a single infrastructure to provide security and cloud computing services as well as content delivery.
Akamai’s culture continued to earn our company recognition as a great place to work. The Wall Street Journal also once again named Akamai to its list of America’s best-run companies, The Management Top 250. This ranking of management effectiveness by the Drucker Institute analyzed publicly traded companies on 34 indicators across customer satisfaction, innovation, financial strength, employee engagement and development, and social responsibility.
I thank our highly talented employees for their hard work in a year that was especially difficult for people in certain parts of the world. Their work is what enables Akamai to make life better for billions of people, trillions of times a day.
Pay vs Performance Disclosure Unit_pure in Millions |
12 Months Ended |
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Pay vs Performance Disclosure |
|
|
|
|
Pay vs Performance Disclosure, Table |
Pay Versus Performance Table The following table sets forth information with respect to the relationship between “compensation actually paid” to our NEOs, as calculated in accordance with Item 402(v) of Regulation S-K, during the years ended December 31, 2023, 2022, 2021 and 2020 and certain measures of Akamai’s financial performance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of Initial Fixed $100 Investment Based On: |
|
|
|
|
Year |
|
Summary Compensation Table Total for PEO |
|
Compensation Actually Paid to PEO |
|
Average Summary Compensation Table Total for Non-PEO NEOs |
|
Average Compensation Actually Paid to Non-PEO NEOs |
|
Total Shareholder Return ($)(5) |
|
Peer Group Total Shareholder Return ($)(6) |
|
Net Income (in millions) ($)(7) |
|
Revenue (adjusted for foreign exchange) (millions)(8) |
|
|
(b) |
|
(c) |
|
(d) |
|
(e) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
13,384,975 |
|
26,216,684 |
|
5,081,479 |
|
9,458,077 |
|
194 |
|
330 |
|
548 |
|
3,819 |
|
|
|
|
|
|
|
|
|
2022 |
|
11,982,771 |
|
3,458,806 |
|
4,379,755 |
|
1,991,599 |
|
98 |
|
139 |
|
524 |
|
3,611 |
|
|
|
|
|
|
|
|
|
2021 |
|
11,951,574 |
|
15,731,346 |
|
4,290,989 |
|
3,045,520 |
|
135 |
|
194 |
|
652 |
|
3,340 |
|
|
|
|
|
|
|
|
|
2020 |
|
11,750,560 |
|
15,604,323 |
|
4,546,391 |
|
5,773,706 |
|
122 |
|
144 |
|
557 |
|
3,114 |
(1) |
Dr. Leighton served as our principal executive officer for 2023, 2022, 2021 and 2020. |
(2) |
The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Dr. Leighton, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Leighton during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Leighton’s total compensation for each year to determine the compensation actually paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEO |
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
Summary Compensation Table (“SCT”) Total |
|
13,384,975 |
|
11,982,771 |
|
11,951,574 |
|
11,750,560 |
|
|
|
|
|
: grant date fair values of equity awards reported in “Stock Awards” column of the SCT for the covered fiscal year (“FY”) |
|
(13,384,974) |
|
(11,982,770) |
|
(11,951,573) |
|
(11,750,559) |
|
|
|
|
|
: fair values as of the end of the covered FY of all equity awards granted during the covered FY that are outstanding and unvested as of the end of such covered FY |
|
20,398,512 |
|
8,045,760 |
|
11,728,701 |
|
11,130,343 |
|
|
|
|
|
: the change in fair value (whether positive or negative) as of the end of the covered FY of any equity awards granted in any prior FY that are outstanding and unvested as of the end of such covered FY |
|
4,190,798 |
|
(4,463,964) |
|
354,691 |
|
1,391,687 |
|
|
|
|
|
: for awards that are granted and vest in the same FY, the fair value as of the vesting date |
|
2,340,475 |
|
929,828 |
|
2,104,593 |
|
1,699,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEO |
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
: the change in fair value (whether positive or negative) as of the vesting date (from the end of the prior FY) of any awards granted in any prior FY for which all applicable vesting conditions were satisfied at the end of or during the covered FY |
|
(713,102) |
|
(1,052,819) |
|
1,543,360 |
|
1,383,205 |
|
|
|
|
|
: for any awards granted in any prior FY that failed to meet the applicable vesting conditions during the covered FY, the fair value at the end of the prior FY |
|
0 |
|
0 |
|
0 |
|
0 |
|
|
|
|
|
Compensation Actually Paid to PEO |
|
26,216,684 |
|
3,458,806 |
|
15,731,346 |
|
15,604,323 |
(3) |
The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s NEOs as a group (excluding Dr. Leighton, who has served as our Chief Executive Officer since 2013) in the “Total” column of the Summary Compensation Table in each applicable year. NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2022 and 2023, Messrs. McGowan, Joseph, Karon and Sundaram; (ii) for 2021, Dr. Blumofe and Messrs. McGowan, Karon, Ahola and McConnell, who served as our President and General Manager of the Security Technology Group until December 13, 2021; and (iii) for 2020, Dr. Blumofe and Messrs. McGowan, Karon and McConnell. |
(4) |
The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the NEOs as a group (excluding Dr. Leighton), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the NEOs during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the average total compensation of the NEOs as a group (other than Dr. Leighton) for each year to determine the compensation actually paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
Average Summary Compensation Table Total |
|
5,081,479 |
|
4,379,755 |
|
4,290,989 |
|
4,546,391 |
|
|
|
|
|
: average grant date fair values of equity awards reported in “Stock Awards” column of the SCT for the covered FY |
|
(4,564,229) |
|
(3,864,442) |
|
(3,775,373) |
|
(4,035,141) |
|
|
|
|
|
: average fair value as of the end of the covered FY of all equity awards granted during the covered FY that are outstanding and unvested as of the end of such covered FY |
|
7,110,263 |
|
2,574,199 |
|
2,642,420 |
|
3,800,353 |
|
|
|
|
|
: the average change in fair value (whether positive or negative) as of the end of the covered FY of any equity awards granted in any prior FY that are outstanding and unvested as of the end of such covered FY |
|
1,286,940 |
|
(1,161,319) |
|
74,157 |
|
487,128 |
|
|
|
|
|
: for awards that are granted and vest in the same FY, the average fair value as of the vesting date |
|
730,130 |
|
289,287 |
|
686,227 |
|
597,004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
: the average change in fair value (whether positive or negative) as of the vesting date of any awards granted in any prior FY for which all applicable vesting conditions were satisfied at the end of or during the covered FY |
|
(186,506) |
|
(225,881) |
|
387,129 |
|
377,971 |
|
|
|
|
|
: for any awards granted in any prior FY that failed to meet the applicable vesting conditions during the covered FY, the average fair value at the end of the prior FY |
|
0 |
|
0 |
|
(1,260,029) |
|
0 |
|
|
|
|
|
Average Compensation Actually Paid to Non-PEO |
|
9,458,077 |
|
1,991,599 |
|
3,045,520 |
|
5,773,706 |
(5) |
Cumulative TSR is calculated by dividing the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. No dividends were paid by the Company during 2020, 2021, 2022 or 2023. |
(6) |
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is the following published industry index: S&P 500 Information Technology Sector. |
(7) |
The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year. |
(8) |
The dollar amounts reported represent the amount of revenue (adjusted for foreign exchange), which is defined as revenue calculated in accordance with GAAP, adjusted for the impact of fluctuations in foreign exchange rates and other non-recurring or unusual items that may arise from time to time. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that revenue, as adjusted for foreign exchange, is the financial performance measure that, in the Company’s assessment, represents the most important financial performance measure that is not otherwise required to be disclosed in the Pay Versus Performance table used by the Company to link compensation actually paid to the Company’s NEOs (as computed in accordance with Item 402(v) of Regulation S-K), for the most recently completed fiscal year, to Company performance. The Company utilizes revenue, as adjusted for foreign exchange, as a performance metric in the Company’s short-term incentive compensation program, as well as for the PRSUs that are awarded to the NEOs. |
|
|
|
|
Company Selected Measure Name |
revenue (adjusted for foreign exchange)
|
|
|
|
Named Executive Officers, Footnote |
The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s NEOs as a group (excluding Dr. Leighton, who has served as our Chief Executive Officer since 2013) in the “Total” column of the Summary Compensation Table in each applicable year. NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2022 and 2023, Messrs. McGowan, Joseph, Karon and Sundaram; (ii) for 2021, Dr. Blumofe and Messrs. McGowan, Karon, Ahola and McConnell, who served as our President and General Manager of the Security Technology Group until December 13, 2021; and (iii) for 2020, Dr. Blumofe and Messrs. McGowan, Karon and McConnell.
|
|
|
|
Peer Group Issuers, Footnote |
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is the following published industry index: S&P 500 Information Technology Sector.
|
|
|
|
PEO Total Compensation Amount |
$ 13,384,975
|
$ 11,982,771
|
$ 11,951,574
|
$ 11,750,560
|
PEO Actually Paid Compensation Amount |
$ 26,216,684
|
3,458,806
|
15,731,346
|
15,604,323
|
Adjustment To PEO Compensation, Footnote |
(2) |
The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Dr. Leighton, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Leighton during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Leighton’s total compensation for each year to determine the compensation actually paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEO |
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
Summary Compensation Table (“SCT”) Total |
|
13,384,975 |
|
11,982,771 |
|
11,951,574 |
|
11,750,560 |
|
|
|
|
|
: grant date fair values of equity awards reported in “Stock Awards” column of the SCT for the covered fiscal year (“FY”) |
|
(13,384,974) |
|
(11,982,770) |
|
(11,951,573) |
|
(11,750,559) |
|
|
|
|
|
: fair values as of the end of the covered FY of all equity awards granted during the covered FY that are outstanding and unvested as of the end of such covered FY |
|
20,398,512 |
|
8,045,760 |
|
11,728,701 |
|
11,130,343 |
|
|
|
|
|
: the change in fair value (whether positive or negative) as of the end of the covered FY of any equity awards granted in any prior FY that are outstanding and unvested as of the end of such covered FY |
|
4,190,798 |
|
(4,463,964) |
|
354,691 |
|
1,391,687 |
|
|
|
|
|
: for awards that are granted and vest in the same FY, the fair value as of the vesting date |
|
2,340,475 |
|
929,828 |
|
2,104,593 |
|
1,699,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEO |
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
: the change in fair value (whether positive or negative) as of the vesting date (from the end of the prior FY) of any awards granted in any prior FY for which all applicable vesting conditions were satisfied at the end of or during the covered FY |
|
(713,102) |
|
(1,052,819) |
|
1,543,360 |
|
1,383,205 |
|
|
|
|
|
: for any awards granted in any prior FY that failed to meet the applicable vesting conditions during the covered FY, the fair value at the end of the prior FY |
|
0 |
|
0 |
|
0 |
|
0 |
|
|
|
|
|
Compensation Actually Paid to PEO |
|
26,216,684 |
|
3,458,806 |
|
15,731,346 |
|
15,604,323 |
|
|
|
|
Non-PEO NEO Average Total Compensation Amount |
$ 5,081,479
|
4,379,755
|
4,290,989
|
4,546,391
|
Non-PEO NEO Average Compensation Actually Paid Amount |
$ 9,458,077
|
1,991,599
|
3,045,520
|
5,773,706
|
Adjustment to Non-PEO NEO Compensation Footnote |
(4) |
The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the NEOs as a group (excluding Dr. Leighton), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the NEOs during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the average total compensation of the NEOs as a group (other than Dr. Leighton) for each year to determine the compensation actually paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
Average Summary Compensation Table Total |
|
5,081,479 |
|
4,379,755 |
|
4,290,989 |
|
4,546,391 |
|
|
|
|
|
: average grant date fair values of equity awards reported in “Stock Awards” column of the SCT for the covered FY |
|
(4,564,229) |
|
(3,864,442) |
|
(3,775,373) |
|
(4,035,141) |
|
|
|
|
|
: average fair value as of the end of the covered FY of all equity awards granted during the covered FY that are outstanding and unvested as of the end of such covered FY |
|
7,110,263 |
|
2,574,199 |
|
2,642,420 |
|
3,800,353 |
|
|
|
|
|
: the average change in fair value (whether positive or negative) as of the end of the covered FY of any equity awards granted in any prior FY that are outstanding and unvested as of the end of such covered FY |
|
1,286,940 |
|
(1,161,319) |
|
74,157 |
|
487,128 |
|
|
|
|
|
: for awards that are granted and vest in the same FY, the average fair value as of the vesting date |
|
730,130 |
|
289,287 |
|
686,227 |
|
597,004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
: the average change in fair value (whether positive or negative) as of the vesting date of any awards granted in any prior FY for which all applicable vesting conditions were satisfied at the end of or during the covered FY |
|
(186,506) |
|
(225,881) |
|
387,129 |
|
377,971 |
|
|
|
|
|
: for any awards granted in any prior FY that failed to meet the applicable vesting conditions during the covered FY, the average fair value at the end of the prior FY |
|
0 |
|
0 |
|
(1,260,029) |
|
0 |
|
|
|
|
|
Average Compensation Actually Paid to Non-PEO |
|
9,458,077 |
|
1,991,599 |
|
3,045,520 |
|
5,773,706 |
|
|
|
|
Compensation Actually Paid vs. Total Shareholder Return |
Compensation Actually Paid and Cumulative TSR The following graph shows the relationship between the amount of compensation actually paid to Dr. Leighton and the average amount of compensation actually paid to the Company’s other NEOs as a group (in each case, as computed in accordance with Item 402(v) of Regulation S-K) and the Company’s cumulative TSR over the four years presented in the Pay Versus Performance table as well as the Company’s peer group TSR over the four years presented in the Pay Versus Performance table.
|
|
|
|
Compensation Actually Paid vs. Net Income |
Compensation Actually Paid and Net Income The following graph shows the relationship between the amount of compensation actually paid to Dr. Leighton and the average amount of compensation actually paid to the Company’s other NEOs as a group (in each case, as computed in accordance with Item 402(v) of Regulation S-K) and the Company’s net income over the four years presented in the Pay Versus Performance table. The Company does not use net income as a performance measure in its executive compensation program.
|
|
|
|
Compensation Actually Paid vs. Company Selected Measure |
Compensation Actually Paid and Revenue (adjusted for foreign exchange) The following graph shows the relationship between the amount of compensation actually paid to Dr. Leighton and the average amount of compensation actually paid to the Company’s other NEOs as a group (in each case, as computed in accordance with Item 402(v) of Regulation S-K) and the Company’s revenue (adjusted for foreign exchange) over the four years presented in the Pay Versus Performance table.
|
|
|
|
Total Shareholder Return Vs Peer Group |
Compensation Actually Paid and Cumulative TSR The following graph shows the relationship between the amount of compensation actually paid to Dr. Leighton and the average amount of compensation actually paid to the Company’s other NEOs as a group (in each case, as computed in accordance with Item 402(v) of Regulation S-K) and the Company’s cumulative TSR over the four years presented in the Pay Versus Performance table as well as the Company’s peer group TSR over the four years presented in the Pay Versus Performance table.
|
|
|
|
Tabular List, Table |
Financial Performance Measures The metrics that the Company uses for both our long-term and short-term incentive awards are selected based on an objective of incentivizing our NEOs to increase long-term value of the Company for our shareholders. The most important financial performance measures used by the Company to link executive compensation actually paid (as computed in accordance with Item 402(v) of Regulation S-K) to the Company’s NEOs, for the most recently completed fiscal year, to the Company’s performance are as follows:
|
|
|
Revenue (adjusted for foreign exchange); |
|
|
|
Non-GAAP earnings per share; and |
|
|
|
Non- GAAP operating income. |
|
|
|
|
Total Shareholder Return Amount |
$ 194
|
98
|
135
|
122
|
Peer Group Total Shareholder Return Amount |
330
|
139
|
194
|
144
|
Net Income (Loss) |
$ 548,000,000
|
$ 524,000,000
|
$ 652,000,000
|
$ 557,000,000
|
Company Selected Measure Amount |
3,819
|
3,611
|
3,340
|
3,114
|
PEO Name |
Dr. Leighton
|
|
|
|
Measure:: 1 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Revenue (adjusted for foreign exchange)
|
|
|
|
Measure:: 2 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Non-GAAP earnings per share
|
|
|
|
Measure:: 3 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Non-GAAP operating income
|
|
|
|
PEO | Stock Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
$ (13,384,974)
|
$ (11,982,770)
|
$ (11,951,573)
|
$ (11,750,559)
|
PEO | All Equity Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
20,398,512
|
8,045,760
|
11,728,701
|
11,130,343
|
PEO | Equity Awards Granted [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
4,190,798
|
(4,463,964)
|
354,691
|
1,391,687
|
PEO | Granted and Vest [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
2,340,475
|
929,828
|
2,104,593
|
1,699,087
|
PEO | Positive Or Negative In Vesting Conditions [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(713,102)
|
(1,052,819)
|
1,543,360
|
1,383,205
|
PEO | Failed To Meet The Applicable Vesting Conditions [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
0
|
0
|
0
|
0
|
Non-PEO NEO | Stock Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(4,564,229)
|
(3,864,442)
|
(3,775,373)
|
(4,035,141)
|
Non-PEO NEO | All Equity Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
7,110,263
|
2,574,199
|
2,642,420
|
3,800,353
|
Non-PEO NEO | Equity Awards Granted [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
1,286,940
|
(1,161,319)
|
74,157
|
487,128
|
Non-PEO NEO | Granted and Vest [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
730,130
|
289,287
|
686,227
|
597,004
|
Non-PEO NEO | Positive Or Negative In Vesting Conditions [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(186,506)
|
(225,881)
|
387,129
|
377,971
|
Non-PEO NEO | Failed To Meet The Applicable Vesting Conditions [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
$ 0
|
$ 0
|
$ (1,260,029)
|
$ 0
|